Bone Biologics Corp
BBLGNasdaqCIK 1419554HealthcareFiscal year ends Dec 31
Reports and events: 214 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2617:00 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001493152-26-048571 |
| 2026-09-2917:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-044889 |
| 2026-09-1617:00 ET | 8-K | 3.01 Delisting notice | 0001493152-26-042940 |
| 2026-08-2817:27 ET | DEF 14A | Proxy statementPeriod 2026-08-28 | 0001493152-26-040640 |
| 2026-08-1417:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038482 |
| 2026-07-2308:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034334 |
| 2026-07-1617:25 ET | 8-K | 8.01 Other events | 0001493152-26-033586 |
| 2026-07-0916:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032694 |
| 2026-07-0208:00 ET | DEF 14A | Proxy statementPeriod 2026-07-02 | 0001493152-26-031652 |
| 2026-05-1417:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023163 |
| 2026-03-1316:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-010080 |
| 2026-03-0216:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-008564 |
| 2026-01-0808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000896 |
| 2025-11-1416:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023563 |
| 2025-09-0407:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012604 |
| 2025-08-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011993 |
| 2025-06-3016:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017165 |
| 2025-06-2616:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016664 |
| 2025-06-2416:10 ET | S-1 | Registration statement | 0001641172-25-016289 |
| 2025-06-0608:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013937 |
| 2025-05-3017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013084 |
| 2025-05-1217:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009746 |
| 2025-04-2308:00 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-005775 |
| 2025-04-1117:00 ET | 8-K | 3.01 Delisting notice | 0001641172-25-003880 |
| 2025-04-0117:15 ET | 8-K | 5.08 Item not in the standard list | 0001641172-25-002130 |
| 2025-02-2617:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-008383 |
| 2024-12-1317:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050025 |
| 2024-11-1417:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-046020 |
| 2024-10-2108:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-041710 |
| 2024-10-0417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-039554 |
| 2024-09-2717:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-038583 |
| 2024-09-1917:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-037146 |
| 2024-08-0916:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030982 |
| 2024-08-0808:00 ET | DEF 14A | Proxy statementPeriod 2024-08-08 | 0001493152-24-030670 |
| 2024-08-0208:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029978 |
| 2024-06-2008:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024426 |
| 2024-05-1416:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019271 |
| 2024-03-1516:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-010114 |
| 2024-03-0616:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-009033 |
| 2024-03-0108:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-008412 |
| 2024-02-2616:50 ET | S-1/A | Registration statement, amended | 0001493152-24-007837 |
| 2024-02-2317:09 ET | S-1/A | Registration statement, amended | 0001493152-24-007706 |
| 2024-02-2117:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-007432 |
| 2024-01-3017:09 ET | S-1 | Registration statement | 0001493152-24-004349 |
| 2024-01-1217:15 ET | 8-K | 8.01 Other events | 0001493152-24-002233 |
| 2024-01-1108:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-002010 |
| 2024-01-1008:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-001892 |
| 2024-01-0217:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-000132 |
| 2023-12-1808:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045193 |
| 2023-12-1309:15 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001493152-23-044661 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:12 ET. Listed shows no prices and gives no investment advice.